Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.74% | 167.10 | 0.7% | $1252.89m | |
| PFE | Pfizer Inc. | -0.05% | 37.25 | 0.9% | $1192.58m | |
| LLY | Eli Lilly & Co. | 0.58% | 213.75 | 1.1% | $1023.62m | |
| ABBV | AbbVie, Inc. | -0.22% | 110.26 | 1.9% | $759.26m | |
| AZN | AstraZeneca Plc | 0.78% | 54.43 | 1.2% | $709.82m | |
| MRK | Merck & Co., Inc. | -0.01% | 81.14 | 0.7% | $707.88m | |
| BMY | Bristol-Myers Squibb Co. | 0.00% | 64.83 | 1.0% | $702.75m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 0.00% | 69.44 | 0.0% | $238.08m | |
| VTRS | Viatris, Inc. | 0.00% | 17.23 | 0.0% | $198.15m | |
| GRTS | Gritstone Oncology, Inc. | 0.00% | 23.86 | 0.0% | $188.77m | |
| NVS | Novartis AG | -4.00% | 94.57 | 0.2% | $182.38m | |
| RPRX | Royalty Pharma Plc | 0.00% | 51.50 | 0.2% | $180.84m | |
| GSK | GlaxoSmithKline Plc | 0.39% | 39.06 | 0.2% | $162.63m | |
| SNY | Sanofi | -0.20% | 49.53 | 0.2% | $138.66m | |
| TAK | Takeda Pharmaceutical Co., Ltd. | 0.16% | 18.40 | 0.0% | $81.39m |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.